☰

Whitney Pope - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Area:
Glioblastoma
Tree Info Grants Similar researchers PubMed Report error

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Aftab K, Aamir FB, Mallick S, Mubarak F, Pope WB, Mikkelsen T, Rock JP, Enam SA. Radiomics for precision medicine in glioblastoma. Journal of Neuro-Oncology. PMID 35020109 DOI: 10.1007/s11060-021-03933-1  0.554
2020 Shen G, Wang R, Gao B, Zhang Z, Wu G, Pope W. The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China. Frontiers in Oncology. 10: 852. PMID 32582544 DOI: 10.3389/Fonc.2020.00852  0.358
2019 Schiff D, van den Bent M, Vogelbaum MA, Wick W, Miller CR, Taphoorn M, Pope W, Brown PD, Platten M, Jalali R, Armstrong T, Wen PY. Recent Developments and Future Directions in Adult Lower-Grade Gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) Consensus. Neuro-Oncology. PMID 30753579 DOI: 10.1093/Neuonc/Noz033  0.388
2019 Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, et al. PET Imaging in Patients with Brain Metastasis - Report of the RANO/PET Group. Neuro-Oncology. PMID 30615138 DOI: 10.1093/Neuonc/Noz003  0.369
2019 Yao J, Nathanson D, Yong WH, Salamon N, Lai A, Leia Nghiemphu P, Prins R, Pope W, Czernin J, Everson R, Liau L, Cloughesy T, Ellingson B. NIMG-60. IDH MUTANT GLIOMAS WITH 1p/19q CO-DELETION ARE LESS ACIDIC THAN NON-CO-DELETED GLIOMAS AS MEASURED WITH PH-WEIGHTED AMINE CEST-MRI AND AMINO ACID PET Neuro-Oncology. 21: vi174-vi175. DOI: 10.1093/Neuonc/Noz175.729  0.332
2019 Patel K, Raymond C, Yao J, Tsung J, Goldman J, Schlossman J, Tran C, Brenner A, Butowski N, Wen P, Pope W, Ji M, Lai A, Leia Nghiemphu P, Rachmilewitz Minei T, et al. NIMG-54. DIFFUSION MRI PHENOTYPES PREDICT OVERALL SURVIVAL BENEFIT FROM BEVACIZUMAB IN RECURRENT GLIOBLASTOMA WITH A LARGE TUMOR BURDEN: EVIDENCE FROM CLINICAL PRACTICE AND A MULTICENTER PHASE 3 TRIAL Neuro-Oncology. 21: vi173-vi173. DOI: 10.1093/Neuonc/Noz175.723  0.425
2019 Elahi L, Garrett M, Guo L, Condro M, Kawaguchi R, Mehta S, Lai A, Pope W, Kornblum H. CBMT-31. HDAC INHIBITION DIMINISHES THE GROWTH OF ENDOGENOUS IDH MUTANT GLIOMAS Neuro-Oncology. 21: vi39-vi40. DOI: 10.1093/Neuonc/Noz175.153  0.34
2018 Patel CB, Fazzari E, Chakhoyan A, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM. F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study. Journal of Neuro-Oncology. PMID 29679199 DOI: 10.1007/S11060-018-2877-6  0.311
2018 Pope WB. Brain metastases: neuroimaging. Handbook of Clinical Neurology. 149: 89-112. PMID 29307364 DOI: 10.1016/B978-0-12-811161-1.00007-4  0.317
2017 de Oliveira EA, Lazovic J, Guo L, Soto H, Faintuch BL, Akhtari M, Pope W. Evaluation of Magnetonanoparticles Conjugated with New Angiogenesis Peptides in Intracranial Glioma Tumors by MRI. Applied Biochemistry and Biotechnology. PMID 28281182 DOI: 10.1007/S12010-017-2443-2  0.349
2017 Ellingson B, Abrey L, Nelson S, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason W, Wick W, Butowski N, Ligon K, Gerstner E, Colman H, Taylor J, ... ... Pope W, et al. NIMG-84. TUMOR LOCATION IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS Neuro-Oncology. 19: vi161-vi161. DOI: 10.1093/Neuonc/Nox168.654  0.359
2017 Ellingson B, Abrey L, Nelson S, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason W, Wick W, Butowski N, Ligon K, Gerstner E, Colman H, de Groot J, ... ... Pope W, et al. NIMG-53. POST-SURGICAL, RESIDUAL ENHANCING TUMOR VOLUME IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS Neuro-Oncology. 19: vi154-vi154. DOI: 10.1093/Neuonc/Nox168.627  0.369
2017 Ellingson B, Gerstner E, Smits M, Huang R, Colen R, Abrey L, Aftab D, Schwab G, Hessel C, Gahrmann R, Pope W, de Groot J, Wen P, Batchelor T, van den Bent M, et al. NIMG-01. DIFFUSION MRI PHENOTYPES PREDICT OVERALL SURVIVAL BENEFIT FROM ANTI-VEGF MONOTHERAPY IN GLIOBLASTOMA AT FIRST OR SECOND RELAPSE Neuro-Oncology. 19: vi142-vi143. DOI: 10.1093/Neuonc/Nox168.582  0.301
2016 Pennington JD, Kaprealian TB, Pouratian N, Pope W, Kupelian PA, Ellingson B. Institutional Adoption of a Standardized Brain Tumor Imaging Protocol Speeds Time From Consult to Stereotactic Radiosurgery for Brain Metastases. International Journal of Radiation Oncology, Biology, Physics. 96: E101-E102. PMID 27673779 DOI: 10.1016/J.Ijrobp.2016.06.847  0.337
2016 Hathout L, Ellingson B, Pope W. Modeling the Efficacy of the Extent of Surgical Resection in the Setting of Radiation Therapy for GBM. Cancer Science. PMID 27240229 DOI: 10.1111/Cas.12979  0.362
2016 Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougère C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-Oncology. PMID 27106405 DOI: 10.1093/Neuonc/Now058  0.304
2016 Harris R, Liau L, Leu K, Nghiemphu P, Pope W, Lai A, Cloughesy T, Ellingson B. NIMG-54. AMINE CEST MRI, A FAST AMINO ACID AND PH-WEIGHTED MOLECULAR IMAGING TECHNIQUE, CORRELATES WITH 18F-FDOPA PET AND IMAGE-GUIDED BIOPSY IN HUMAN GLIOMA Neuro-Oncology. 18: vi136-vi136. DOI: 10.1093/Neuonc/Now212.565  0.308
2016 Ellingson B, Abrey L, Garcia J, Chinot O, Aftab D, Schwab G, Revil C, Saran F, Nishikawa R, Henriksson R, Hessel C, Harris R, Woodworth D, Leu K, Lai A, ... ... Pope W, et al. NIMG-31. RESIDUAL ENHANCING TUMOR VOLUME IS A STRONG PROGNOSTIC BIOMARKER FOR SURVIVAL IN BOTH NEWLY DIAGNOSED AND RECURRENT GBM REGARDLESS OF THERAPY: EVIDENCE FROM 1,535 PATIENTS IN SINGLE AND MULTICENTER TRIALS Neuro-Oncology. 18: vi131-vi131. DOI: 10.1093/Neuonc/Now212.543  0.374
2015 Galldiks N, Langen KJ, Pope WB. From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors? Neuro-Oncology. 17: 1434-44. PMID 26130743 DOI: 10.1093/neuonc/nov118  0.31
2015 Okada H, Weller M, Huang R, Finocchiaro G, Gilbert M, Wick W, Ellingson B, Hashimoto N, Pollack I, Brandes A, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope W, et al. NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov225.56  0.374
2015 Leu K, Boxerman J, Cloughesy T, Lai A, Nghiemphu P, Liau L, Pope W, Ellingson B. NIMG-25IMPROVED LEAKAGE CORRECTION FOR DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) PERFUSION MRI ESTIMATES OF RELATIVE CEREBRAL BLOOD VOLUME (rCBV) IN HIGH-GRADE GLIOMAS BY ACCOUNTING FOR BIDIRECTIONAL CONTRAST AGENT EXCHANGE Neuro-Oncology. 17: v159.1-v159. DOI: 10.1093/Neuonc/Nov225.25  0.31
2015 Ellingson B, Leu K, Pope W, Lai A, Nghiemphu P, Liau L, Cloughesy T. NIMG-24HIGH SPATIOTEMPORAL DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) PERFUSION MRI USING MULTIBAND ECHOPLANAR IMAGING (MB-EPI) Neuro-Oncology. 17: v158.4-v159. DOI: 10.1093/Neuonc/Nov225.24  0.333
2014 Leu K, Tran A, Pope W, Lai A, Nghiemphu P, Harris R, Woodworth D, Cloughesy T, Ellingson B. NI-55 * PARAMETRIC MAPS OF CONTRAST AGENT DIFFUSION USING A NOVEL DIFFUSION-PERFUSION MODEL APPLIED TO DCE-MRI CAN DIFFERENTIATE NON-ENHANCING TUMOR FROM EDEMA IN HUMAN GLIOBLASTOMA Neuro-Oncology. 16: v150-v150. DOI: 10.1093/Neuonc/Nou264.53  0.365
2014 Leu K, Enzmann D, Woodworth D, Teixeira S, Lai A, Nghiemphu P, Pope W, Cloughesy T, Ellingson B. NI-54 * HYPERVASCULAR VOLUME ESTIMATED BY COMPARISON TO A LARGE-SCALE CEREBRAL BLOOD VOLUME (CBV) RADIOGRAPHIC ATLAS PREDICTS SURVIVAL IN RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB Neuro-Oncology. 16: v150-v150. DOI: 10.1093/Neuonc/Nou264.52  0.397
2014 Huang R, Rahman R, Pope W, Ellingson B, Ballman K, Felton S, Anderson SK, Nayak L, Lee E, Abrey L, Galanis E, Reardon D, Cloughesy T, Wen P. NI-36 * VALIDATION OF RANO CRITERIA: CONTRIBUTION OF T2/FLAIR ASSESSMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB Neuro-Oncology. 16: v145-v146. DOI: 10.1093/Neuonc/Nou264.34  0.334
2014 Hardy A, Prins R, Kong X, Woodworth D, Pope W, Yong W, Cloughesy T, Liau L, Ellingson B. NI-32 * ENHANCING TUMOR RESPONSE USING QUANTITATIVE VOLUMETRY FROM T1 SUBTRACTION MAPS IN MALIGNANT GLIOMA TREATED WITH DENDRITIC CELL VACCINATION Neuro-Oncology. 16: v145-v145. DOI: 10.1093/Neuonc/Nou264.30  0.368
2014 Ellingson B, Pope W, Nghiemphu P, Lai A, Cloughesy T. NI-22 * NON-ENHANCING TUMOR RESPONSE USING QUANTITATIVE T2 MAPS PREDICTS SURVIVAL IN GLIOBLASTOMA TREATED WITH BEVACIZUMAB Neuro-Oncology. 16: v142-v143. DOI: 10.1093/Neuonc/Nou264.21  0.349
2014 Ellingson B, Kim G, Woodworth D, Pope W, Nghiemphu P, Lai A, Cloughesy T. NI-21 * CONTRAST ENHANCED T1 SUBTRACTION MAPS IMPROVE DETECTION OF RESIDUAL TUMOR FOLLOWING RESECTION, REDUCES MEASUREMENT VARIABILITY, AND PREDICTS SURVIVAL AFTER ANTI-ANGIOGENIC THERAPY IN GLIOBLASTOMA Neuro-Oncology. 16: v142-v142. DOI: 10.1093/Neuonc/Nou264.20  0.382
2014 Ellingson B, Chang W, Harris R, Mody R, Lai A, Nghiemphu P, Cloughesy T, Pope W. NI-20 * ADC HISTOGRAM ANALYSIS FOLLOWING RADIOTHERAPY PREDICTS RESPONSE TO ADJUVANT TEMOZOLOMIDE IN NEWLY DIAGNOSED GBM Neuro-Oncology. 16: v142-v142. DOI: 10.1093/Neuonc/Nou264.19  0.392
2014 Harris R, Cloughesy T, Liau L, Lai A, Nghiemphu P, Li D, Pope W, Ellingson B. BI-10 * pH-WEIGHTED MRI IN HUMAN GLIOMAS Neuro-Oncology. 16: v25-v25. DOI: 10.1093/Neuonc/Nou239.10  0.355
2013 Akhtari M, Pope W, Mathern G, Moats R, Frew A, Mandelkern M. Functionalized magnetonanoparticles in visualization of intracranial tumors on MRI. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 299-306. PMID 23184607 DOI: 10.1007/S11307-012-0601-Z  0.355
2011 Gomez C, Wu J, Pope W, Vinters H, Desalles A, Selch M. Pineocytoma with diffuse dissemination to the leptomeninges. Rare Tumors. 3: e53. PMID 22355508 DOI: 10.4081/Rt.2011.E53  0.365
2010 Wagle N, Nghiemphu L, Lai A, Pope W, Mischel PS, Cloughesy T. Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumab. Pharmacogenomics and Personalized Medicine. 3: 79-85. PMID 23226044 DOI: 10.2147/Pgpm.S7940  0.355
2009 Ledezma CJ, Chen W, Sai V, Freitas B, Cloughesy T, Czernin J, Pope W. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience. European Journal of Radiology. 71: 242-8. PMID 18511228 DOI: 10.1016/J.Ejrad.2008.04.018  0.339
2009 Huo J, Okada K, Kim HJ, Pope WB, Goldin JG, Alger JR, Brown MS. CADrx for GBM brain tumors: Predicting treatment response from changes in diffusion-weighted MRI Algorithms. 2: 1350-1367. DOI: 10.3390/A2041350  0.304
2008 Morioka CA, El-Saden S, Pope W, Sayre J, Duckwiler G, Meng F, Bui A, Kangarloo H. A methodology to integrate clinical data for the efficient assessment of brain-tumor patients. Informatics For Health & Social Care. 33: 55-68. PMID 18604762 DOI: 10.1080/17538150801956762  0.363
2008 Lai A, Filka E, McGibbon B, Nghiemphu PL, Graham C, Yong WH, Mischel P, Liau LM, Bergsneider M, Pope W, Selch M, Cloughesy T. Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability. International Journal of Radiation Oncology, Biology, Physics. 71: 1372-80. PMID 18355978 DOI: 10.1016/J.Ijrobp.2007.11.068  0.311
2007 Chen W, Delaloye S, Silverman DH, Geist C, Czernin J, Sayre J, Satyamurthy N, Pope W, Lai A, Phelps ME, Cloughesy T. Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4714-21. PMID 17947718 DOI: 10.1200/Jco.2006.10.5825  0.385
2006 Pope WB, Lai A, Nghiemphu P, Mischel P, Cloughesy TF. MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology. 66: 1258-60. PMID 16636248 DOI: 10.1212/01.Wnl.0000250628.10420.D8  0.305
1994 Pope WB, Lambert MP, Leypold B, Seupaul R, Sletten L, Krafft G, Klein WL. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y. Experimental Neurology. 126: 185-94. PMID 7925819 DOI: 10.1006/Exnr.1994.1057  0.355
1993 Pope W, Enam SA, Bawa N, Miller BE, Ghanbari HA, Klein WL. Phosphorylated tau epitope of Alzheimer's disease is coupled to axon development in the avian central nervous system. Experimental Neurology. 120: 106-13. PMID 7682967 DOI: 10.1006/Exnr.1993.1044  0.56
1992 Tsui HC, Pope WB, Kim CS, Klein WL. Transient expression of adheron molecules during chick retinal development. Journal of Neurobiology. 23: 720-38. PMID 1431842 DOI: 10.1002/neu.480230610  0.337
Show low-probability matches.